Abstract Details
|
Monica B. Dhakar, MBBS
(Xenon Pharmaceuticals)
PRESENTER |
Dr. Dhakar has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Dhakar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Dhakar has or had stock in Xenon Pharmaceuticals Inc. The institution of an immediate family member of Dr. Dhakar has received research support from NIH. The institution of an immediate family member of Dr. Dhakar has received research support from Medtronics. |
| Pamela Z. New, MD, FAAN | No disclosure on file |
| Fen Bao | Fen Bao has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Carla E. Santiago-Martinez (Wayne State University) | Ms. Santiago-Martinez has nothing to disclose. |
| Deepti Zutshi, MD, FAAN (Wayne State University School of Medicine) | Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta. |
| Maysaa M. Basha, MD, FAAN (Wayne State University, Detroit Medical Center) | Dr. Basha has nothing to disclose. |
| Aashit K. Shah, MD, FAAN (Carilion Clinic) | Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma. |
| Omar A. Khan, MD, PhD (Dept of Neuro/Wayne State Univ Sch of Med) | No disclosure on file |